Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-17

Clinical Trial Update: High Intensity Focused Ultrasound (HIFU) Ablation System Study [Phase 3]

View source ↗

Summary

A Phase 3 study of ProRhythm's High Intensity Focused Ultrasound ablation system for atrial fibrillation has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ProRhythm, Inc. | Conditions: Atrial Fibrillation | Phase 3 | Status: SUSPENDED